Ishita P Miah1, Yeliz Tank2, Frits R Rosendaal3, Wilco C Peul4,5, Ruben Dammers6, Hester F Lingsma7, Heleen M den Hertog8, Korné Jellema5, Niels A van der Gaag5,9. 1. Department of Neurology and Neurosurgery, Leiden University Medical Center (LUMC), Albinusdreef 2, 2333, ZA, Leiden, The Netherlands. i.p.miah@lumc.nl. 2. Department of Radiology, Leiden University Medical Center (LUMC), Albinusdreef 2, 2333, ZA, Leiden, The Netherlands. 3. Department of Clinical Epidemiology, Leiden University Medical Center (LUMC), Albinusdreef 2, 2333, ZA, Leiden, The Netherlands. 4. Department of Neurology and Neurosurgery, Leiden University Medical Center (LUMC), Albinusdreef 2, 2333, ZA, Leiden, The Netherlands. 5. Department of Neurology and Neurosurgery, Haaglanden Medical Center (HMC), Lijnbaan 32, 2512, VA, The Hague, The Netherlands. 6. Department of Neurosurgery, Erasmus Medical Center (EMC), Erasmus MC Stroke Center, Dr. Molewaterplein 40, 3015, GD, Rotterdam, The Netherlands. 7. Department of Public Health and Medical Decision Making, Erasmus Medical Center (EMC), Dr. Molewaterplein 40, 3015, GD, Rotterdam, The Netherlands. 8. Department of Neurology, Isala Hospital Zwolle, Dokter van Heesweg 2, 8025, AB, Zwolle, The Netherlands. 9. Department of Neurosurgery, Haga Teaching Hospital, Els Borst-Eilersplein 275, 2545, AA, The Hague, The Netherlands.
Abstract
PURPOSE: Chronic subdural hematoma (CSDH) is associated with high recurrence rates. Radiographic prognostic factors may identify patients who are prone for recurrence and who might benefit further optimization of therapy. In this meta-analysis, we systematically evaluated pre-operative radiological prognostic factors of recurrence after surgery. METHODS: Electronic databases were searched until September 2020 for relevant publications. Studies reporting on CSDH recurrence in symptomatic CSDH patients with only surgical treatment were included. Random or fixed effects meta-analysis was used depending on statistical heterogeneity. RESULTS: Twenty-two studies were identified with a total of 5566 patients (mean age 69 years) with recurrence occurring in 801 patients (14.4%). Hyperdense components (hyperdense homogeneous and mixed density) were the strongest prognostic factor of recurrence (pooled RR 2.83, 95% CI 1.69-4.73). Laminar and separated architecture types also revealed higher recurrence rates (RR 1.37, 95% CI 1.04-1.80 and RR 1.76 95% CI 1.38-2.16, respectively). Hematoma thickness and midline shift above predefined cut-off values (10 mm and 20 mm) were associated with an increased recurrence rate (RR 1.79, 95% CI 1.45-2.21 and RR 1.38, 95% CI 1.11-1.73, respectively). Bilateral CSDH was also associated with an increased recurrence risk (RR 1.34, 95% CI 0.98-1.84). LIMITATIONS: Limitations were no adjustments for confounders and variable data heterogeneity. Clinical factors could also be predictive of recurrence but are beyond the scope of this study. CONCLUSIONS: Hyperdense hematoma components were the strongest prognostic factor of recurrence after surgery. Awareness of these findings allows for individual risk assessment and might prompt clinicians to tailor treatment measures.
PURPOSE:Chronic subdural hematoma (CSDH) is associated with high recurrence rates. Radiographic prognostic factors may identify patients who are prone for recurrence and who might benefit further optimization of therapy. In this meta-analysis, we systematically evaluated pre-operative radiological prognostic factors of recurrence after surgery. METHODS: Electronic databases were searched until September 2020 for relevant publications. Studies reporting on CSDH recurrence in symptomatic CSDH patients with only surgical treatment were included. Random or fixed effects meta-analysis was used depending on statistical heterogeneity. RESULTS: Twenty-two studies were identified with a total of 5566 patients (mean age 69 years) with recurrence occurring in 801 patients (14.4%). Hyperdense components (hyperdense homogeneous and mixed density) were the strongest prognostic factor of recurrence (pooled RR 2.83, 95% CI 1.69-4.73). Laminar and separated architecture types also revealed higher recurrence rates (RR 1.37, 95% CI 1.04-1.80 and RR 1.76 95% CI 1.38-2.16, respectively). Hematoma thickness and midline shift above predefined cut-off values (10 mm and 20 mm) were associated with an increased recurrence rate (RR 1.79, 95% CI 1.45-2.21 and RR 1.38, 95% CI 1.11-1.73, respectively). Bilateral CSDH was also associated with an increased recurrence risk (RR 1.34, 95% CI 0.98-1.84). LIMITATIONS: Limitations were no adjustments for confounders and variable data heterogeneity. Clinical factors could also be predictive of recurrence but are beyond the scope of this study. CONCLUSIONS:Hyperdense hematoma components were the strongest prognostic factor of recurrence after surgery. Awareness of these findings allows for individual risk assessment and might prompt clinicians to tailor treatment measures.
Authors: Jiri Bartek; Kristin Sjåvik; Helena Kristiansson; Fredrik Ståhl; Ida Fornebo; Petter Förander; Asgeir S Jakola Journal: World Neurosurg Date: 2017-07-19 Impact factor: 2.104
Authors: Bert Bosche; Marek Molcanyi; Thomas Noll; Matthias Kochanek; Bastian Kraus; Bernhard Rieger; Faycal El Majdoub; Christian Dohmen; Mario Löhr; Roland Goldbrunner; Gerrit Brinker Journal: Clin Neurol Neurosurg Date: 2012-04-26 Impact factor: 1.876
Authors: John K Yue; Alexander F Haddad; Albert S Wang; David J Caldwell; Gray Umbach; Anthony M Digiorgio; Phiroz E Tarapore; Michael C Huang; Geoffrey T Manley Journal: Trauma Case Rep Date: 2022-06-28
Authors: Sae Min Kwon; Min Ho Lee; Youngbeom Seo; Young Il Kim; Hyuk-Jin Oh; Kyung Hwan Kim; Kyu-Sun Choi; Kyuha Chong Journal: Korean J Neurotrauma Date: 2022-04-25
Authors: Giancarlo Mignucci-Jiménez; Alejandro J Matos-Cruz; Irakliy Abramov; Sahin Hanalioglu; Melissa S Kovacs; Mark C Preul; Caleb E Feliciano-Valls Journal: Surg Neurol Int Date: 2022-06-03
Authors: H M Abdullah; T Dakurah; H Akoto; B Abaidoo; J C B Dakubo; A E Yawson; G Wepeba; P Bankah; J Boatey; M Ametefe; F Nketiah-Boakye; A Fuseini; M Banson; T Ndanu; A Mubarak; M Iddrissu Journal: BMC Neurol Date: 2022-09-14 Impact factor: 2.903
Authors: Hyuk-Jin Oh; Youngbeom Seo; Yoon-Hee Choo; Young Il Kim; Kyung Hwan Kim; Sae Min Kwon; Min Ho Lee; Kyuha Chong Journal: J Korean Neurosurg Soc Date: 2021-11-04